Novo Nordisk A/S (NVO) Reports Positive Results From First Phase 3 Trial With Long-Acting Factor IX for Treatment of Hemophilia B
5/17/2013
More...
|
Safety Results From Auris Medical AG's Clinical Development of AM-101 Presented at International Conference
5/17/2013
More...
|
AREVA Med LLC Med Presents Pharmacokinetics Data From Phase 1 Clinical Trial at SNMMI
5/17/2013
More...
|
FDA Approves Janssen Biotech Inc.'s Simponi to Treat Ulcerative Colitis
5/16/2013
More...
|
Transgenomic, Inc. (TBIO) Announces Global Availability of CRC RAScan Mutation Detection Test for Use in Patients With Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
5/16/2013
More...
|
Promedior to Present Clinical Data on Lead Drug Candidate, PRM-151, in Patients With IPF at the American Thoracic Society 2013 Annual Meeting
5/16/2013
More...
|
Successful Phase One Demonstrates Tumor Response With Increased Overall Survival for Lead VBL Therapeutics Compound in Cancer
5/16/2013
More...
|
Jennerex, Inc. Announces Science Translational Medicine Publication Highlighting Pexa-Vec's Ability to Induce Functional Anti-Cancer Immunity in Patients With Diverse Tumor Types
5/16/2013
More...
|
Advanced Cell Technology Confirms Clinical Trial Participant Showed Improvement in Vision From 20/400 to 20/40 Following Treatment
5/16/2013
More...
|
TopoTarget A/S Release: Final Data From BELIEF Study for American Society of Clinical Oncology 2013 Confirms Objective Response Rate of 26%
5/16/2013
More...
|
NeoStem, Inc. Announces Geographic Expansion of Intellectual Property Coverage of Cardiovascular Asset AMR-001
5/16/2013
More...
|
Receptos to Deliver Scientific Presentations at Digestive Disease Week 2013 About the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease
5/16/2013
More...
|
Ultragenyx Pharmaceuticals Advances Clinical Development of UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
5/15/2013
More...
|
GENFIT Corp. (ALGFT) Release: GFT505 Reduces the Risk of Cardiovascular Events Through Its Action on Remnant Cholesterol
5/15/2013
More...
|
OncoMed Pharmaceuticals, Inc. Initiates Phase 1b/2 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 (Anti-Notch2/3) in Small Cell Lung Cancer (SCLC) and Amends Phase1b/2 Pancreatic Cancer Trial
5/15/2013
More...
|